Hospital
Integris Miami Hospital
Integris Miami Hospital was paid $7.24M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99283, emergency room visit (moderate) — 57% of everything it billed.
33Billing provider infoINTEGRIS MIAMI HOSPITAL
MIAMI, OK 74354
MIAMI, OK 74354
33aNPI1114931342assigned 07/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.24M
24GClaims78,344
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#18 of 75
Median peer was paid$3.66M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WALLACE, DONNA controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,249 | $706K | |
| 2019 | 8,876 | $854K | |
| 2020 | 6,579 | $684K | |
| 2021 | 10,438 | $1.09M | |
| 2022 | 16,837 | $1.60M | |
| 2023 | 19,277 | $1.50M | |
| 2024incomplete | 9,088 | $816K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 57% | 25,878 | 25,420 | $4.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 5,630 | 5,539 | $1.25M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.0% | 2,231 | 2,205 | $654K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.8% | 2,364 | 2,325 | $278K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 1,421 | 1,388 | $127K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 3,837 | 799 | $121K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 607 | 302 | $112K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 621 | 610 | $44K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 615 | 175 | $41K |
| 87400 | <1% | 1,584 | 1,560 | $38K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 237 | 236 | $38K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 955 | 947 | $34K |
42 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 6,310 | $32K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,270 | $28K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 181 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,640 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 467 | $21K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 157 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 269 | $21K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 248 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 2,293 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 607 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 870 | $18K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,313 | $16K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 493 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 350 | $13K |
| 85027 | <1% | 1,923 | $12K | |
| 87430 | <1% | 760 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,291 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 507 | $8K |
| 87070 | <1% | 657 | $7K | |
| 81003 | <1% | 1,655 | $7K | |
| 81025 | <1% | 823 | $6K | |
| 81001 | <1% | 2,293 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 89 | $3K |
| 84484 | <1% | 292 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 537 | $3K |
| 83690 | <1% | 432 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 135 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 18 | $2K |
| 83605 | <1% | 147 | $2K | |
| 87807 | <1% | 86 | $990.25 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $950.20 |
| 87420 | <1% | 40 | $472.40 | |
| 83880 | <1% | 12 | $419.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $209.16 |
| 82550 | <1% | 26 | $144.75 | |
| 97597 | <1% | 23 | $139.04 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 261 | $20.44 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 181 | $0.55 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 39 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 245 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 1,252 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 146 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALLACE, DONNA (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Integris Canadian Valley Hospital | Yukon, OK | $7.12M |
| Integris Bass Baptist Health Center | Enid, OK | $6.42M |
| Integris Grove Hospital | Grove, OK | $5.80M |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $818K |
| Integris Grove Hospital | Grove, OK | $444K |
| Integris Bass Baptist Health Center | Medford, OK | $376K |
| Integris Bass Baptist Health Center | Waynoka, OK | $303K |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $79K |
| Integris Health Woodward Hospital INC | Woodward, OK | $71K |
| Integris Health Woodward Hospital INC | Woodward, OK | $68K |
| Integris Health Woodward Hospital INC | Woodward, OK | $32K |
| Integris Health Woodward Hospital INC | Woodward, OK | $19K |
| Integris Health Woodward Hospital INC | Mooreland, OK | $6K |
| Integris Health Woodward Hospital INC | Woodward, OK | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.